ArticleAmerican journal of translational research2025
Comparative efficacy of laparoscopic Dor and Nissen fundoplication for refractory gastroesophageal reflux disease.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the clinical efficacy of laparoscopic Dor versus Nissen fundoplication in the treatment of refractory gastroesophageal reflux disease (RGERD).
methodsThis retrospective study included 102 RGERD patients treated between January 2023 and January 2025. Patients were assigned to either the Dor (n=50) or the Nissen (n=52) groups based on the surgical approach. Outcomes compared included overall clinical efficacy, perioperative indicators (intraoperative blood loss, operative time, and hospital stay), time to symptomatic improvement (reflux, burning epigastric discomfort, and retrosternal pain), esophageal manometry (integrated relaxation pressure [IRP] and lower esophageal sphincter resting pressure [LESP]), esophageal pH monitoring (reflux duration, reflux episodes, and DeMeester score), Gastroesophageal Reflux Disease Questionnaire (GERDQ) score, adverse events during hospitalization and at 1-year follow-up (heartburn, constipation, eructation disorder, acid regurgitation, bloating, and dysphagia), and patient satisfaction.
resultsThe two surgical techniques demonstrated no marked difference in overall efficacy rates, perioperative parameters, time to symptomatic improvement, incidence of adverse events (8.00% vs. 13.46%), or treatment satisfaction (82.00% vs. 76.92%; all P>0.05). Both groups showed significant postoperative increases in IRP and LESP and marked reductions in reflux duration and episodes, as well as DeMeester and GERDQ scores (all P<0.05), though no statistical inter-group differences were identified (P>0.05).
conclusionsDor and Nissen fundoplication demonstratede equivalent effectiveness and safety in the treatment of RGERD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.